ANI Pharmaceuticals, Inc. (ANIP)
80.39
+0.94
(+1.18%)
USD |
NASDAQ |
May 01, 16:00
80.33
-0.06
(-0.07%)
Pre-Market: 20:00
ANI Pharmaceuticals Market Cap : 1.829B for May 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Liquidia Corp. | 3.390B |
| Catalyst Pharmaceuticals, Inc. | 3.510B |
| Indivior Pharmaceuticals, Inc. | 4.557B |
| Replimune Group, Inc. | 206.43M |
| ADMA Biologics, Inc. | 2.505B |
Market Cap Related Metrics
| PE Ratio | 23.99 |
| PS Ratio | 1.893 |
| Price to Book Value | 3.382 |
| Price to Free Cash Flow | 11.08 |
| Price | 80.39 |
| Earnings Yield | 4.17% |
| Operating PE Ratio | 20.59 |
| Normalized PE Ratio | 35.85 |